A role for fulvestrant monotherapy in the first-line treatment of ER plus metastatic breast cancer?

被引:2
|
作者
Mahtani, Reshma L. [1 ]
机构
[1] Univ Miami Hlth Syst, Div Hematol Oncol, Sylvester Comprehens Canc Ctr, 1192 East Newport Ctr Dr, Deerfield Beach, FL 33442 USA
来源
BREAST JOURNAL | 2020年 / 26卷 / 02期
关键词
POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; ANASTROZOLE; ABEMACICLIB; THERAPY; COMBINATION; PALBOCICLIB;
D O I
10.1111/tbj.13495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:109 / 111
页数:3
相关论文
共 50 条
  • [1] First-line Herceptin® monotherapy in metastatic breast cancer
    Vogel, CL
    Cobleigh, MA
    Tripathy, D
    Gutheil, JC
    Harris, LN
    Fehrenbacher, L
    Slamon, DJ
    Murphy, M
    Novotny, WF
    Burchmore, M
    Shak, S
    Stewart, SJ
    ONCOLOGY, 2001, 61 : 37 - 42
  • [2] First-line treatment of metastatic breast cancer
    Trudeau, ME
    ANTI-CANCER DRUGS, 1996, 7 : 9 - 12
  • [3] Gemcitabine plus vinorelbine as first-line treatment of metastatic breast cancer.
    Gokmen, E
    Sezgin, C
    Karabulut, B
    Vazquez, A
    Sanal, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 85S - 85S
  • [4] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    T Gamucci
    A M D'Ottavio
    E Magnolfi
    M Barduagni
    A Vaccaro
    I Sperduti
    L Moscetti
    F Belli
    L Meliffi
    British Journal of Cancer, 2007, 97 : 1040 - 1045
  • [5] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    Gamucci, T.
    D'Ottavio, A. M.
    Magnolfi, E.
    Barduagni, M.
    Vaccaro, A.
    Sperduti, I.
    Moscetti, L.
    Belli, F.
    Meliffi, L.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1040 - 1045
  • [6] The role of capecitabine in first-line treatment for patients with metastatic breast cancer
    Gelmon, Karen
    Chan, Arlene
    Harbeck, Nadia
    ONCOLOGIST, 2006, 11 : 42 - 51
  • [7] Fulvestrant (F) as first-line palliative treatment for hormone receptor (HR)- positive metastatic breast cancer
    Bartsch, R.
    Wenzel, C.
    Ziebermayr, R.
    Bago-Horvath, Z.
    Pluschnig, U.
    Dubsky, P. C.
    Rudas, M.
    Gnant, M.
    Zielinski, C.
    Steger, G. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Bevacizumab in first-line treatment of metastatic breast cancer
    Miles, David
    DRUGS, 2007, 67 (12) : 1800 - 1800
  • [9] BevacizumabIn First-Line Treatment of Metastatic Breast Cancer
    Lesley J. Scott
    Drugs, 2007, 67 : 1793 - 1799
  • [10] Bevacizumab in the first-line treatment of metastatic breast cancer
    Cameron, David
    EJC SUPPLEMENTS, 2008, 6 (06): : 21 - 28